🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/12/2025 | 100,30 | 100,34 | 96,79 | 98,27 | -1,98% | 3,54% | 16.663.600 |
| 15/12/2025 | 99,99 | 100,94 | 98,00 | 100,26 | -0,04% | 2,94% | 16.735.900 |
| 12/12/2025 | 98,96 | 100,66 | 98,32 | 100,30 | +1,30% | 2,36% | 11.810.800 |
| 11/12/2025 | 98,44 | 99,14 | 97,58 | 99,01 | +1,42% | 1,58% | 11.808.200 |
| 10/12/2025 | 98,05 | 98,17 | 96,47 | 97,62 | +0,75% | 1,73% | 18.077.700 |
| 09/12/2025 | 99,32 | 99,85 | 96,06 | 96,89 | -2,06% | 3,82% | 16.283.900 |
| 08/12/2025 | 99,38 | 99,67 | 97,81 | 98,93 | -0,79% | 1,87% | 12.902.600 |
| 05/12/2025 | 101,40 | 102,09 | 99,19 | 99,72 | -1,16% | 2,86% | 16.430.400 |
| 04/12/2025 | 102,10 | 102,60 | 100,54 | 100,89 | -1,35% | 2,02% | 12.770.700 |
| 03/12/2025 | 101,90 | 103,09 | 101,52 | 102,27 | +1,23% | 1,54% | 12.541.600 |
| 02/12/2025 | 101,53 | 101,80 | 100,31 | 101,03 | -0,79% | 1,47% | 11.795.000 |
| 01/12/2025 | 104,72 | 105,68 | 101,71 | 101,83 | -2,86% | 3,79% | 14.178.300 |
| 28/11/2025 | 104,84 | 105,41 | 104,12 | 104,83 | +0,19% | 1,23% | 6.154.500 |
| 26/11/2025 | 104,60 | 105,75 | 104,20 | 104,63 | -0,97% | 1,48% | 12.624.000 |
| 25/11/2025 | 100,73 | 105,84 | 100,71 | 105,66 | +5,24% | 5,09% | 22.225.500 |
| 24/11/2025 | 99,12 | 102,36 | 99,12 | 100,40 | +2,70% | 3,27% | 28.320.900 |
| 21/11/2025 | 95,48 | 100,27 | 95,36 | 97,76 | +2,94% | 5,14% | 23.183.300 |
| 20/11/2025 | 94,97 | 96,00 | 93,90 | 94,97 | -0,08% | 2,21% | 12.554.200 |
| 19/11/2025 | 96,00 | 97,14 | 94,09 | 95,05 | -1,43% | 3,18% | 14.641.300 |
| 18/11/2025 | 94,11 | 97,66 | 92,11 | 96,43 | +3,84% | 5,90% | 28.153.500 |
| 17/11/2025 | 93,23 | 94,75 | 92,68 | 92,86 | -0,06% | 2,22% | 14.345.800 |
| 14/11/2025 | 92,20 | 95,08 | 91,49 | 92,92 | -0,01% | 3,89% | 19.632.000 |
| 13/11/2025 | 91,31 | 94,26 | 90,90 | 92,93 | +1,62% | 3,68% | 16.086.100 |
| 12/11/2025 | 91,41 | 92,91 | 91,16 | 91,45 | +0,55% | 1,91% | 13.218.900 |
| 11/11/2025 | 87,35 | 91,07 | 87,26 | 90,95 | +4,84% | 4,36% | 15.436.000 |
| 10/11/2025 | 86,69 | 87,37 | 85,80 | 86,75 | +0,54% | 1,81% | 8.319.600 |
| 07/11/2025 | 85,95 | 86,59 | 85,24 | 86,28 | +0,58% | 1,57% | 9.214.300 |
| 06/11/2025 | 84,48 | 86,17 | 84,35 | 85,78 | +1,65% | 2,15% | 10.601.400 |
| 05/11/2025 | 84,03 | 85,38 | 82,91 | 84,39 | +0,63% | 2,94% | 9.440.200 |
| 04/11/2025 | 82,70 | 84,96 | 82,01 | 83,86 | +1,66% | 3,57% | 12.846.100 |